Trial record 14 of 103 for:
Open Studies | "Aortic Aneurysm"
Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms
This study is currently recruiting participants.
Verified August 2012 by Lee, W. Anthony, M.D. FACS
Sponsor:
Lee, W. Anthony, M.D. FACS
Collaborator:
William Cook Australia
Information provided by (Responsible Party):
Lee, W. Anthony, M.D. FACS
ClinicalTrials.gov Identifier:
NCT01524211
First received: January 30, 2012
Last updated: August 29, 2012
Last verified: August 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to collect information on the Cook Zenith t-Branch endovascular stent-graft system for the treatment of aortic aneurysms.
| Condition | Intervention | Phase |
|---|---|---|
|
Thoracoabdominal Aortic Aneurysm |
Device: Zenith® t-Branch |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms |
Resource links provided by NLM:
Further study details as provided by Lee, W. Anthony, M.D. FACS:
Primary Outcome Measures:
- Early Mortality [ Time Frame: 30 days post implant of the branch endografts ] [ Designated as safety issue: No ]The primary aim of this study is to determine the rate of early mortality after branch endograft treatment.
Secondary Outcome Measures:
- Rates of Neurologic Complications/Late Branch Vessel Patency [ Time Frame: Day 0-Day 30 (Early) Day 31-1825 (Late) ] [ Designated as safety issue: No ]The secondary aims of this study are to determine the rates of neurologic complications and late branch vessel patency after branch endograft treatment, and the fractional/proportional/percent applicability/eligibility of the (standard, off-the-shelf) Zenith® t-Branch in all patients who present with thoracoabdominal aortic aneurysms
| Estimated Enrollment: | 30 |
| Study Start Date: | January 2012 |
| Estimated Study Completion Date: | January 2019 |
| Estimated Primary Completion Date: | January 2014 (Final data collection date for primary outcome measure) |
Intervention Details:
Detailed Description:
-
Device: Zenith® t-Branch
The t-Branch Endovascular Graft (Zenith® t-Branch) is a tubular graft with four branches and a covered stent at the proximal end that contains barbs for additional fixation of the device. The purpose of the branches is to allow uninterrupted blood flow to visceral vessels of the aorta. The graft is designed to be connected with celiac, superior mesenteric and two renal arteries via self-expanding covered bridging stents. Although the standard Zenith t-Branch has four branches, it is anticipated that a small number of custom-made three branch devices will be included in this study for those patients in whom one of the visceral vessels is chronically thrombosed.
Study Update as of 8/29/2012
14 Subjects successfully have been implanted with the Zenith t-Branch Device to date and recruitment is ongoing
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
Subject must have one of the following:
- Degenerative, atherosclerotic thoracoabdominal aortic aneurysm (fusiform or saccular): ≥55mm in diameter or
- Thoracoabdominal aortic aneurysm with a history of growth ≥0.5 cm per year.
- Penetrating ulcers: ≥20mm in depth or
- Chronic type B aortic dissections: ≥55mm total aortic diameter or
- Symptomatic pathology (aneurysm, ulcer or chronic dissection) of any size
Exclusion Criteria:
- Life-expectancy less than 12 months
- Refusal to receive blood products
- Age <18 years
- Pregnant or breastfeeding or planning on becoming pregnant within 60 months
- Unwilling to comply with the follow-up schedule
- Inability or refusal to give informed consent
Medical Exclusion Criteria
- Uncontrolled systemic infection
- Untreatable malignancy
- MI or stroke in last 90 days
- Unstable/Ruptured aneurysm
- Uncontrollable anaphylaxis to iodinated contrast
- Known allergy(ies) to device materials
- History of chronic abdominal pain
- Coagulopathy or any bleeding disorder
- Contraindication to general anesthesia
Anatomic Exclusion Criteria
- Any pathology of mycotic origin
- Aortic fistulous communication with non-vascular structure (e.g. esophagus, bronchial)
- Extensive thrombus or calcifications in the aortic arch
- Excessive tortuosity precluding safe passage of the Zenith® t-Branch or its components
- Inability to insert the Zenith® t-Branch device through iliofemoral approach
- Proximal and distal neck angle less than 90 degrees relative to the long axis of the aneurysm
- Proximal landing zone length <25mm to allow secure fixation and seal
- Proximal landing zone diameter of <24mm or >38mm
- Distal landing zone length <25mm in the abdominal aorta or <20mm in the iliac arteries
- Distal landing zone diameter of <24mm or >30mm in the abdominal aorta, or <7mm or >20mm in the iliac arteries
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01524211
Contacts
| Contact: Lisamarie Kernicky, RN;BSN;CCRC | 561-955-5239 | lkernicky@brrh.com |
Locations
| United States, Florida | |
| Boca Raton Regional Hospital (BRRH) | Recruiting |
| Boca Raton, Florida, United States, 33486 | |
| Contact: Lisamarie Kernicky, RN;BSN;CCRC 561-955-5239 lkernicky@brrh.com | |
Sponsors and Collaborators
Lee, W. Anthony, M.D. FACS
William Cook Australia
Investigators
| Principal Investigator: | W. Anthony Lee, MD | Lynn Heart and Vascular Institute, Boca Raton Regional Hospital |
More Information
No publications provided
| Responsible Party: | Lee, W. Anthony, M.D. FACS |
| ClinicalTrials.gov Identifier: | NCT01524211 History of Changes |
| Other Study ID Numbers: | IDE G110081 |
| Study First Received: | January 30, 2012 |
| Last Updated: | August 29, 2012 |
| Health Authority: | United States: Food and Drug Administration United States: Institutional Review Board |
Keywords provided by Lee, W. Anthony, M.D. FACS:
|
Aortic Aneurysms |
Additional relevant MeSH terms:
|
Aneurysm Aortic Aneurysm Aortic Aneurysm, Thoracic |
Vascular Diseases Cardiovascular Diseases Aortic Diseases |
ClinicalTrials.gov processed this record on May 23, 2013